Korsana Biosciences raises $175m Series A

Beijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.

Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need.

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

Warp Sciences combines chemistry, AI and robotics to help drug discovery teams make and test molecules in the United States.